TCR-NK Cell Therapy Collaboration

About JURA Bio

JURA Bio is a private, pre-clinical stage biotech leveraging a proprietary, integrated AI and wet-lab platform to discover and develop novel therapeutics. The company's 'sovereign AI' approach uses its VISTA, LIFT, and LeaVS technologies to create a self-improving data generation and model training loop, enabling de novo design across antibodies, TCRs, peptides, and cell therapies. With strategic collaborations already announced, JURA is positioning itself at the frontier of AI-driven drug discovery by attempting to overcome the critical industry bottleneck of high-quality, functional training data.

Therapeutic Areas

Other Cancer Drugs